SCHEMBL6971652

SCHEMBL6971652

CCN1CCN(c2cc(C(F)(F)F)ccn2)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 1/20 0.62
KDM4E B2RXH2 4/20 0.61
CYP2D6 P10635 1/20 0.61
L3MBTL1 Q9Y468 2/20 0.55
PPARG P37231 1/20 0.53
PPARD Q03181 1/20 0.53
PPARA Q07869 1/20 0.53
MAPT P10636 4/20 0.50
ALDH1A1 P00352 3/20 0.49
FFAR4 Q5NUL3 1/20 0.48
LMNA P02545 1/20 0.46
HSD17B10 Q99714 1/20 0.46
PARP1 P09874 1/20 0.45
CXCR3 P49682 1/20 0.45
TRPV1 Q8NER1 2/20 0.45
HRH3 Q9Y5N1 1/20 0.45
KDM2B Q8NHM5 1/20 0.45
TSHR P16473 1/20 0.44
RAF1 P04049 1/20 0.44
BRAF P15056 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22792702 0.87 KDM4E (0.47) ADRB1KDM4ECYP2D6L3MBTL1PPARG
SCHEMBL12968838 0.83 ADRB1 (0.68) ADRB1KDM4ECYP2D6L3MBTL1PPARG
SCHEMBL9725103 0.83 ADRB1 (0.59) ADRB1KDM4ECYP2D6L3MBTL1PPARG
SCHEMBL18176129 0.81 ADRB1 (0.73) ADRB1KDM4ECYP2D6L3MBTL1PPARG
SCHEMBL20013708 0.81 ADRB1 (0.57) ADRB1KDM4ECYP2D6L3MBTL1PPARG
SCHEMBL24008459 0.80 ADRB1 (0.71) ADRB1KDM4ECYP2D6L3MBTL1PPARG
SCHEMBL13018936 0.79 HRH3 (0.65) ADRB1KDM4ECYP2D6L3MBTL1PPARG
SCHEMBL15345047 0.78 DRD4 (0.50) ALDH1A1HRH3DRD2DRD3
SCHEMBL1901605 0.78 ADRB1 (0.69) ADRB1KDM4ECYP2D6L3MBTL1PPARG
SCHEMBL1998032 0.78 ADRB1 (0.69) ADRB1KDM4ECYP2D6L3MBTL1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296954-A1 BICYCLIC LACTAMS AND SULFONAMIDES WITH 5-HT1A-AFFINITY AND USE THEREOF FOR PREVENTING AND TREATING CEREBRAL ISCHAEMIA Abbott GmbH & Co. KG (DE) 2003-04-02 EP disclosed
WO-2002002529-A1 BICYCLIC LACTAMS AND SULFONAMIDES WITH 5-HT1A-AFFINITY AND USE THEREOF FOR PREVENTING AND TREATING CEREBRAL ISCHAEMIA ABBOTT GMBH & CO. KG (DE) 2002-01-10 WO disclosed